1Life Healthcare, Inc. (NASDAQ:ONEM) Holdings Raised by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC increased its holdings in 1Life Healthcare, Inc. (NASDAQ:ONEMGet Rating) by 9.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,959 shares of the company’s stock after acquiring an additional 4,132 shares during the period. Los Angeles Capital Management LLC’s holdings in 1Life Healthcare were worth $384,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Tiger Global Management LLC lifted its stake in 1Life Healthcare by 28.1% in the 1st quarter. Tiger Global Management LLC now owns 17,673,234 shares of the company’s stock worth $195,819,000 after acquiring an additional 3,880,134 shares in the last quarter. Vanguard Group Inc. lifted its stake in 1Life Healthcare by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 14,448,803 shares of the company’s stock worth $160,092,000 after acquiring an additional 324,722 shares in the last quarter. Addition Three General Partner L.P. lifted its stake in 1Life Healthcare by 27.3% in the 1st quarter. Addition Three General Partner L.P. now owns 9,107,802 shares of the company’s stock worth $100,914,000 after acquiring an additional 1,954,000 shares in the last quarter. Sheares Healthcare Group Pte. Ltd. lifted its stake in 1Life Healthcare by 0.3% in the 1st quarter. Sheares Healthcare Group Pte. Ltd. now owns 8,321,731 shares of the company’s stock worth $92,205,000 after acquiring an additional 21,252 shares in the last quarter. Finally, State Street Corp raised its stake in shares of 1Life Healthcare by 8.4% during the 1st quarter. State Street Corp now owns 2,721,393 shares of the company’s stock worth $30,153,000 after purchasing an additional 210,424 shares in the last quarter. 79.58% of the stock is owned by hedge funds and other institutional investors.

1Life Healthcare Stock Performance

ONEM opened at $16.81 on Friday. The stock’s 50 day moving average price is $17.08 and its two-hundred day moving average price is $13.32. The company has a quick ratio of 2.06, a current ratio of 2.09 and a debt-to-equity ratio of 0.20. 1Life Healthcare, Inc. has a 12-month low of $5.94 and a 12-month high of $22.69. The firm has a market capitalization of $3.44 billion, a P/E ratio of -8.32 and a beta of 2.16.

1Life Healthcare (NASDAQ:ONEMGet Rating) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.57) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.19). 1Life Healthcare had a negative return on equity of 23.82% and a negative net margin of 39.15%. The firm had revenue of $261.37 million during the quarter, compared to the consensus estimate of $273.51 million. During the same quarter in the prior year, the business posted ($0.51) EPS. 1Life Healthcare’s revenue was up 72.7% compared to the same quarter last year. On average, equities analysts forecast that 1Life Healthcare, Inc. will post -1.96 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ONEM shares. Piper Sandler raised their price target on 1Life Healthcare to $18.00 in a research note on Friday, July 22nd. Credit Suisse Group downgraded 1Life Healthcare from an “outperform” rating to a “neutral” rating and set a $18.00 price target for the company. in a research note on Thursday, October 27th. Citigroup downgraded 1Life Healthcare from a “buy” rating to a “neutral” rating and raised their price target for the stock from $14.00 to $18.00 in a research note on Friday, July 22nd. Truist Financial lowered 1Life Healthcare from a “buy” rating to a “hold” rating and set a $18.00 price objective on the stock. in a report on Monday, July 25th. Finally, Barclays lowered 1Life Healthcare from an “overweight” rating to an “equal weight” rating and increased their price objective for the company from $15.00 to $18.00 in a report on Thursday, July 21st. Thirteen analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.27.

Insiders Place Their Bets

In other 1Life Healthcare news, General Counsel Lisa A. Mango sold 1,602 shares of the firm’s stock in a transaction that occurred on Friday, October 21st. The stock was sold at an average price of $17.08, for a total value of $27,362.16. Following the completion of the sale, the general counsel now owns 88,385 shares in the company, valued at approximately $1,509,615.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other 1Life Healthcare news, General Counsel Lisa A. Mango sold 1,602 shares of the firm’s stock in a transaction that occurred on Friday, October 21st. The stock was sold at an average price of $17.08, for a total value of $27,362.16. Following the completion of the sale, the general counsel now owns 88,385 shares in the company, valued at approximately $1,509,615.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Bjorn B. Thaler sold 10,417 shares of the firm’s stock in a transaction that occurred on Tuesday, November 1st. The stock was sold at an average price of $17.10, for a total value of $178,130.70. Following the transaction, the chief financial officer now owns 14,479 shares of the company’s stock, valued at approximately $247,590.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,264,502 shares of company stock worth $72,836,446. 4.40% of the stock is currently owned by company insiders.

1Life Healthcare Company Profile

(Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

Further Reading

Institutional Ownership by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.